Full Text
The Full Text of this article is available as a PDF (77.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adami H. O., Baron J. A., Rothman K. J. Ethics of a prostate cancer screening trial. Lancet. 1994 Apr 16;343(8903):958–960. doi: 10.1016/s0140-6736(94)90071-x. [DOI] [PubMed] [Google Scholar]
- Aronowitz R. To screen or not to screen: What is the question? J Gen Intern Med. 1995 May;10(5):295–297. doi: 10.1007/BF02599892. [DOI] [PubMed] [Google Scholar]
- Catalona W. J. Screening for prostate cancer: enthusiasm. Urology. 1993 Aug;42(2):113–115. doi: 10.1016/0090-4295(93)90632-k. [DOI] [PubMed] [Google Scholar]
- Chodak G. W. Questioning the value of screening for prostate cancer in asymptomatic men. Urology. 1993 Aug;42(2):116–118. doi: 10.1016/0090-4295(93)90633-l. [DOI] [PubMed] [Google Scholar]
- Cole P. The moral bases for public health interventions. Epidemiology. 1995 Jan;6(1):78–83. doi: 10.1097/00001648-199501000-00016. [DOI] [PubMed] [Google Scholar]
- Edwards P. J., Hall D. M. Screening, ethics, and the law. BMJ. 1992 Aug 1;305(6848):267–268. doi: 10.1136/bmj.305.6848.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gillon R. Ethics in health promotion and prevention of disease. J Med Ethics. 1990 Dec;16(4):171–172. doi: 10.1136/jme.16.4.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gohagan J. K., Prorok P. C., Kramer B. S., Cornett J. E. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. J Urol. 1994 Nov;152(5 Pt 2):1905–1909. doi: 10.1016/s0022-5347(17)32412-6. [DOI] [PubMed] [Google Scholar]
- Hahn D. L., Roberts R. G. PSA screening for asymptomatic prostate cancer: truth in advertising. J Fam Pract. 1993 Nov;37(5):432–436. [PubMed] [Google Scholar]
- Holland W. W. Screening: reasons to be cautious. BMJ. 1993 May 8;306(6887):1222–1223. doi: 10.1136/bmj.306.6887.1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horner J. S. Medical ethics and the public health. Public Health. 1992 May;106(3):185–192. doi: 10.1016/s0033-3506(05)80535-9. [DOI] [PubMed] [Google Scholar]
- Kramer B. S., Gohagan J. K., Prorok P. C. Is screening for prostate cancer the current gold standard?--"no". Eur J Cancer. 1997 Mar;33(3):348–353. [PubMed] [Google Scholar]
- Lange P. H. Is screening for prostate cancer the current gold standard?--"yes". Eur J Cancer. 1997 Mar;33(3):354–356. [PubMed] [Google Scholar]
- Mandelson M. T., Wagner E. H., Thompson R. S. PSA screening: a public health dilemma. Annu Rev Public Health. 1995;16:283–306. doi: 10.1146/annurev.pu.16.050195.001435. [DOI] [PubMed] [Google Scholar]
- Mant D., Fowler G. Mass screening: theory and ethics. BMJ. 1990 Apr 7;300(6729):916–918. doi: 10.1136/bmj.300.6729.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marteau T. M. Screening in practice: Reducing the psychological costs. BMJ. 1990 Jul 7;301(6742):26–28. doi: 10.1136/bmj.301.6742.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mettlin C., Jones G., Averette H., Gusberg S. B., Murphy G. P. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin. 1993 Jan-Feb;43(1):42–46. doi: 10.3322/canjclin.43.1.42. [DOI] [PubMed] [Google Scholar]
- Middleton R. G. Prostate cancer: are we screening and treating too much? Ann Intern Med. 1997 Mar 15;126(6):465–467. doi: 10.7326/0003-4819-126-6-199703150-00009. [DOI] [PubMed] [Google Scholar]
- Nijhuis H. G., van der Maesen L. J. The philosophical foundations of public health: an invitation to debate. J Epidemiol Community Health. 1994 Feb;48(1):1–3. doi: 10.1136/jech.48.1.1-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Hagan J. The ethics of informed consent in relation to prevention screening programmes. N Z Med J. 1991 Mar 27;104(908):121–123. [PubMed] [Google Scholar]
- Pellegrino E. D. Autonomy and coercion in disease prevention and health promotion. Theor Med. 1984 Feb;5(1):83–91. doi: 10.1007/BF00489248. [DOI] [PubMed] [Google Scholar]
- Pellegrino E. D. Philosophy of medicine: towards a definition. J Med Philos. 1986 Feb;11(1):9–16. doi: 10.1093/jmp/11.1.9. [DOI] [PubMed] [Google Scholar]
- Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985 Mar;14(1):32–38. doi: 10.1093/ije/14.1.32. [DOI] [PubMed] [Google Scholar]
- Schröder F. H., Bangma C. H. The European Randomized Study of Screening for Prostate Cancer (ERSPC). Br J Urol. 1997 Mar;79 (Suppl 1):68–71. doi: 10.1111/j.1464-410x.1997.tb00804.x. [DOI] [PubMed] [Google Scholar]
- Schröder F. H. Prostate cancer: to screen or not to screen? BMJ. 1993 Feb 13;306(6875):407–408. doi: 10.1136/bmj.306.6875.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Self D. J., Wolinsky F. D., Baldwin D. C., Jr The effect of teaching medical ethics on medical students' moral reasoning. Acad Med. 1989 Dec;64(12):755–759. doi: 10.1097/00001888-198912000-00014. [DOI] [PubMed] [Google Scholar]
- Shy C. M. The failure of academic epidemiology: witness for the prosecution. Am J Epidemiol. 1997 Mar 15;145(6):479–487. doi: 10.1093/oxfordjournals.aje.a009133. [DOI] [PubMed] [Google Scholar]
- Skrabanek P. Why is preventive medicine exempted from ethical constraints? J Med Ethics. 1990 Dec;16(4):187–190. doi: 10.1136/jme.16.4.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Terris M. The Society for Epidemiologic Research (SER) and the future of epidemiology. Am J Epidemiol. 1992 Oct 15;136(8):909–915. doi: 10.1093/oxfordjournals.aje.a116563. [DOI] [PubMed] [Google Scholar]
- Vineis P. Proof in observational medicine. J Epidemiol Community Health. 1997 Feb;51(1):9–13. doi: 10.1136/jech.51.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Voss J. D. Prostate cancer, screening, and prostate-specific antigen: promise or peril? J Gen Intern Med. 1994 Aug;9(8):468–474. doi: 10.1007/BF02599070. [DOI] [PubMed] [Google Scholar]
- Wald N., Law M. Screening, ethics, and the law. BMJ. 1992 Oct 10;305(6858):892–892. doi: 10.1136/bmj.305.6858.892-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weed D. L. Beyond black box epidemiology. Am J Public Health. 1998 Jan;88(1):12–14. doi: 10.2105/ajph.88.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weed D. L. Epidemiology, the humanities, and public health. Am J Public Health. 1995 Jul;85(7):914–918. doi: 10.2105/ajph.85.7.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weed Douglas L. Underdetermination and incommensurability in contemporary epidemiology. Kennedy Inst Ethics J. 1997 Jun;7(2):107–127. doi: 10.1353/ken.1997.0018. [DOI] [PubMed] [Google Scholar]
- Welch H. G. Questions about the value of early intervention. N Engl J Med. 1996 May 30;334(22):1472–1473. doi: 10.1056/NEJM199605303342211. [DOI] [PubMed] [Google Scholar]
- Wilt T. J., Brawer M. K. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol. 1994 Nov;152(5 Pt 2):1910–1914. doi: 10.1016/s0022-5347(17)32413-8. [DOI] [PubMed] [Google Scholar]
- Wolf A. M., Nasser J. F., Wolf A. M., Schorling J. B. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996 Jun 24;156(12):1333–1336. [PubMed] [Google Scholar]
- Woolf S. H. Public health perspective: the health policy implications of screening for prostate cancer. J Urol. 1994 Nov;152(5 Pt 2):1685–1688. doi: 10.1016/s0022-5347(17)32361-3. [DOI] [PubMed] [Google Scholar]
- Woolf S. H. Should we screen for prostate cancer? BMJ. 1997 Apr 5;314(7086):989–990. doi: 10.1136/bmj.314.7086.989. [DOI] [PMC free article] [PubMed] [Google Scholar]